Who owns Royalty Pharma (RPRX)? Superinvestor holders
5 superinvestors of the 157 tracked here hold Royalty Pharma (RPRX) in their latest 13F filing, with $929.7M between them. Pat Dorsey gives it the most weight: 8.23% of the reported portfolio. In their latest reported quarter, Murray Stahl added; Pat Dorsey, Samantha McLemore, Baillie Gifford team and Paul Tudor Jones reduced.
Key facts
- Superinvestors holding it
- 5 of 157
- Biggest holder
- Baillie Gifford team, $534.1M
- Largest weight
- Pat Dorsey, 8.23%of their portfolio
- Combined value
- $929.7M
- Bought last quarter
- 1
- Sold last quarter
- 4
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Pat DorseyDorsey Asset Management | 8.23% | $141M | 2.42M | ▼ Reduced 1.7% | −40.78K | Q3 2026 |
| 2 | Samantha McLemorePatient Capital Management | 6.71% | $199.7M | 3.42M | ▼ Reduced 4.9% | −176.7K | Q3 2026 |
| 3 | Baillie Gifford teamBaillie Gifford & Co | 0.50% | $534.1M | 9.15M | ▼ Reduced 8.6% | −863.32K | Q3 2026 |
| 4 | Murray StahlHorizon Kinetics | 0.26% | $20.6M | 353.19K | ▲ Added 2.4% | +8.35K | Q3 2026 |
| 5 | Paul Tudor JonesTudor Investment Corp | 0.14% | $34.2M | 610.74K | ▼ Reduced 9.1% | −60.92K | Q2 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 4 | 15.34M | $895.4M | 1 | 3 |
| Q2 2026 | 157 | 6 | 18.96M | $1.1B | 3 | 4 |
| Q1 2026 | 157 | 6 | 23.58M | $1.1B | 3 | 3 |
| Q4 2025 | 157 | 6 | 29.15M | $1.1B | 3 | 3 |
| Q3 2025 | 157 | 5 | 24.06M | $848.8M | 4 | 2 |
| Q2 2025 | 157 | 5 | 24.6M | $886.4M | 3 | 2 |
| Q1 2025 | 156 | 5 | 28M | $871.5M | 2 | 3 |
| Q4 2024 | 156 | 5 | 30.27M | $772.2M | 4 | 1 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Baillie Gifford team | 9.15M | 10.02M | 16.16M | 17.01M | 17.37M | 18.02M | 13.4M | 14.13M |
| Samantha McLemore | 3.42M | 3.6M | 3.64M | 3.33M | 3.12M | 2.99M | 2.97M | 2.88M |
| Pat Dorsey | 2.42M | 2.46M | 2.28M | 2.26M | 2.35M | — | — | — |
| Murray Stahl | 353.19K | 344.86K | 340.78K | 353.36K | 354.69K | 353.47K | 329.57K | 319.18K |
| Jim Simons (1938–2024) | — | 1.94M | — | — | — | — | — | — |
| Paul Tudor Jones | · | 610.74K | 671.68K | 924.82K | 863.84K | 642.74K | 727.74K | 735.03K |
| Andrew Spokes | — | — | 493K | — | — | — | — | — |
| Ken Griffin | · | — | — | 5.27M | — | — | — | — |
| Andreas Halvorsen | · | — | — | — | — | 2.6M | 10.56M | 12.21M |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own RPRX?
In their latest 13F filings: Pat Dorsey (8.23% of the portfolio, $141M), Samantha McLemore (6.71% of the portfolio, $199.7M), Baillie Gifford team (0.50% of the portfolio, $534.1M), Murray Stahl (0.26% of the portfolio, $20.6M), Paul Tudor Jones (0.14% of the portfolio, $34.2M).
Who bought RPRX last quarter?
Murray Stahl (added 2.4%). “Last quarter” is each investor's latest reported quarter.
Who sold RPRX last quarter?
Reduced: Pat Dorsey (1.7% fewer shares), Samantha McLemore (4.9% fewer shares), Baillie Gifford team (8.6% fewer shares), Paul Tudor Jones (9.1% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Royalty Pharma (RPRX)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/RPRX/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to RPRX by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.